Enanta Pharmaceuticals (ENTA) EPS (2012 - 2026)
Enanta Pharmaceuticals (ENTA) EPS from Mar 31, 2012 to Mar 31, 2026. The TTM Enanta Pharmaceuticals (ENTA) EPS is -$5.54. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Enanta Pharmaceuticals (ENTA) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +22.63% |
| 3 Years TTM | -19.33% |
| 5 Years TTM | +8.56% |
Annual EPS change of Enanta Pharmaceuticals (ENTA)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.45 | -88.24% |
| 2025 | -$3.83 | -30.07% |
| 2024 | -$5.48 | -13.84% |
| 2023 | -$6.35 | +8.51% |
| 2022 | -$5.86 | +50.01% |
| 2021 | -$3.90 | +116.68% |
| 2020 | -$1.80 | -176.53% |
| 2019 | $2.35 | +75.53% |
| 2018 | $1.34 | +119.34% |
| 2017 | $0.61 | -333.71% |
| 2016 | -$0.26 | -118.70% |
| 2015 | $1.40 | -38.06% |
| 2014 | $2.26 | -854.34% |
| 2013 | -$0.30 | -106.67% |
| 2012 | $4.49 | -785.70% |
| 2011 | -$0.66 | N/A |
Comparison Enanta Pharmaceuticals (ENTA) five years EPS CAGR with competitors
Enanta Pharmaceuticals (ENTA) five years EPS CAGR is 8.56%.